NURS 6501: MIDTERM EXAM: Please contact Assignment Samurai for help with NURS 6501: Midterm Exam or any other assignment. Email: assignmentsamurai@gmail.com   Which immunosuppressive medication is commonly utilized to prevent rejection after organ transplantation and operates primarily through the inhibition of the mTOR pathway, which is instrumental in regulating the transcription and translation of autophagy-related genes (Atg)? Group of answer choices

• Cyclosporine
• Mycophenolate mofetil
• Azathioprine
• Rapamycin

  The correct answer is Rapamycin. Explanation: Rapamycin (also known as sirolimus) is an immunosuppressive medication commonly used to prevent organ transplant rejection. It operates primarily through the inhibition of the mTOR (mechanistic target of rapamycin) pathway. mTOR is a key regulatory protein that controls various cellular processes, including protein synthesis, cell growth, and autophagy. By inhibiting mTOR, rapamycin reduces the transcription and translation of autophagy-related genes (Atg), which are involved in maintaining cellular homeostasis, especially under stress conditions.

• mTOR inhibition also suppresses T-cell activation and proliferation, which is why rapamycin is used as an immunosuppressive agent in organ transplant recipients to prevent rejection.

Why the other options are incorrect:

• Cyclosporine: Cyclosporine is an immunosuppressive drug that works by inhibiting calcineurin, a protein that is crucial for activating T-cells. It does not primarily target the mTOR pathway.
• Mycophenolate mofetil: Mycophenolate mofetil inhibits inosine monophosphate dehydrogenase, which is involved in the purine synthesis pathway. This prevents the proliferation of T- and B-cells, but it does not operate via the mTOR pathway.
• Azathioprine: Azathioprine is a purine analog that also inhibits DNA synthesis, primarily affecting T- and B-cells. Like mycophenolate mofetil, it does not primarily target the mTOR pathway.

Conclusion: Rapamycin is the immunosuppressive medication that operates through the inhibition of the mTOR pathway, which regulates autophagy and is crucial in preventing organ transplant rejection.